Asia-Pacific Breast Reconstruction Market, By Product (Breast Implants, Tissue Expanders, Acellular Dermal Matrix), Type (Unilateral, Bilateral), Shape (Round Implants, Anatomical Implants), Technology (Inframammary, Peri-Areolar, Trans-Axillary, Transumbilical), Placement (Dual-Plane Insertion, Subglandular Insertion, Submuscular Insertion), Procedure (Immediate Procedures, Delayed Procedures, Revision Procedures), End User (Hospitals, Cosmetology Clinics, Ambulatory Surgical Centers, Others) – Industry Trends and Forecast to 2030.
Asia-Pacific Breast Reconstruction Market Analysis and Size
The rising prevalence and incidence of breast cancer, as well as the growing awareness of reconstructive breast surgeries, are driving the growth of the breast reconstruction market. The increasing number of breast cancer patients and the availability of favourable reimbursement policies can be attributed to the growth. Furthermore, an increase in the number of breast reconstruction procedures, as well as technological advances, are expected to drive market growth.
Data Bridge Market Research analyses that the Asia-Pacific breast reconstruction market which was USD 128.88 million in 2022, is expected to reach USD 266.38 million by 2030, at a CAGR of 9.5% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Asia-Pacific Breast Reconstruction Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 20230
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Breast Implants, Tissue Expanders, Acellular Dermal Matrix), Type (Unilateral, Bilateral), Shape (Round Implants, Anatomical Implants), Technology (Inframammary, Peri-Areolar, Trans-Axillary, Transumbilical), Placement (Dual-Plane Insertion, Subglandular Insertion, Submuscular Insertion), Procedure (Immediate Procedures, Delayed Procedures, Revision Procedures), End User (Hospitals, Cosmetology Clinics, Ambulatory Surgical Centers, Others)
|
|
Countries Covered
|
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)
|
|
Market Players Covered
|
POLYTECH Health & Aesthetics GmbH (Germany), CEREPLAS (France), Guangzhou Wanhe Plastic Material Co., Ltd (China), Johnson & Johnson Private Limited (U.S.), GC Aesthetics (U.K.), Laboratories Arion (France), Sientra Inc. (U.S.), HANSBIOMED CO. LTD (South Korea), Sientra, Inc. (U.S.), Deal Implant Incorporated (U.S), Integra LifeSciences (U.S.), PMT Corporation (U.S.), RTI Surgical (U.S.), Establishment Labs S.A. (U.S.), Silimed (Brazil)
|
|
Market Opportunities
|
|
Market Definition
Breast reconstruction is a surgical procedure that reshapes the breasts. Breast implants are used in conjunction with silicone devices filled with silicone gel or salt water (saline) to contour the breasts. Breast implant surgery is a challenging procedure. There are currently several treatments available for breast restoration, including nipple repair and a regenerative medicine approach using 3D Printed Tissue Scaffolds. Nipple reconstruction treatments have advanced from a local skin flagship surgical method to current tissue engineering approaches.
Asia-Pacific Breast Reconstruction Market Dynamics
Drivers
- Growing number of breast reconstruction procedures
An increasing number of breast reconstruction procedures is expected to fuel market growth. According to the NCBI, the rate of post-mastectomy breast reconstruction increased from 19.4% in 2015 to 53.4% in 2018. Furthermore, the American Society of Plastic Surgeons reports that the number of breast reconstruction procedures increased from 78,882 in 2000 to 137,808 in 2020, propelling market growth.
- Rise in number of breast cancer patients
Globally, the number of breast cancer patients has increased. According to the WHO, approximately 2.3 million women worldwide will be diagnosed with breast cancer by 2020. Furthermore, according to a similar source, more than 7.8 million new breast cancer cases were diagnosed between 2015 and 2020. Furthermore, according to Cancer Research UK, approximately 55,900 breast cancer patients are diagnosed in the United Kingdom alone each year. Furthermore, breast cancer is the most common type of cancer in the United Kingdom, according to a similar source. As a result of the increased number of people diagnosed with breast cancer, the demand for breast reconstruction is expected to rise, propelling market growth during the forecast period. Similarly, according to Breast Cancer Now, one in every seven women in the United Kingdom will be diagnosed with breast cancer. As a result of the increased number of people suffering, the market will grow.
Opportunities
- Technological innovations
One of the innovations expected to influence the breast reconstruction markets is 3D printing, which is being used to make soft absorbable shells with silicon filling to integrate with the specific medical requirements of patients. The increasing use of silicone and saline breast implants, ADMs, and tissue expanders is expected to be a major trend in breast reconstruction in the coming years.
Restraints/Challenges
- High cost of surgical expenses
High surgical costs and difficulties, such as adverse effects of surgical operations, changes in nipple and breast sensation, scar development, and, in some cases, rupture with deflation of saline-filled implants associated with breast reconstructions, have stifled the breast reconstruction market's growth. These issues are linked to Acellular Dermal Matrices (ADMs), as hematoma, skin necrosis, and seroma are the most commonly reported complications following ADM breast reconstruction procedures.
This breast reconstruction market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the breast reconstruction market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In 2020, AbbVie Inc. completely acquired Allergan, combining the two companies' product portfolios. This acquisition assisted AbbVie Inc. in increasing its market and demand for its product in the future by combining the product portfolios of both companies, thereby strengthening their business.
- In 2019, Johnson & Johnson Services, Inc.'s brand Mentor received FDA approval for the MemoryShape device under Premarket Approval (PMA) Application. This has aided the company's portfolio expansion in the breast reconstruction implant market.
Asia-Pacific Breast Reconstruction Market Scope
The breast reconstruction market is segmented on the basis of product, type, shape, technology, placement, procedure and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Breast Implants
- Silicone Implants
- Saline Implants
- Tissue Expanders
- Acellular Dermal Matrix
Type
- Unilateral
- Bilateral
Shape
- Round Implants
- Anatomical Implants
Technology
- Inframammary
- Peri-Areolar
- Trans-Axillary
- Transumbilical
Placement
- Dual-Plane Insertion
- Subglandular Insertion
- Submuscular Insertion
Procedure
- Immediate Procedures
- Delayed Procedures
- Revision Procedures
End User
- Hospitals
- Cosmetology Clinics
- Ambulatory Surgical Centers
- Others
Competitive Landscape and Asia-Pacific Breast Reconstruction Market Share Analysis
The breast reconstruction market is analyzed and market size insights and trends are provided by country, product, type, shape, technology, placement, procedure and end user as referenced above.
The countries covered in the breast reconstruction market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).
Japan dominates the Asia-Pacific breast reconstruction market due to rising demand for aesthetic procedures.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The breast reconstruction market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for breast reconstruction market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the breast reconstruction market. The data is available for historic period 2011-2021.
Competitive Landscape and Asia-Pacific Breast Reconstruction Market Share Analysis
The breast reconstruction market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to breast reconstruction market.
Some of the major players operating in the breast reconstruction market are:
- POLYTECH Health & Aesthetics GmbH (Germany)
- CEREPLAS (France)
- Guangzhou Wanhe Plastic Material Co., Ltd (China)
- Johnson & Johnson Private Limited (U.S.)
- GC Aesthetics (U.K.)
- Laboratories Arion (France)
- Sientra Inc. (U.S.)
- HANSBIOMED CO. LTD (South Korea)
- Sientra, Inc. (U.S.)
- Deal Implant Incorporated (U.S.)
- Integra LifeSciences (U.S.)
- PMT Corporation (U.S.)
- RTI Surgical (U.S.)
- Establishment Labs S.A. (U.S.)
- Silimed (Brazil)
SKU-